Methodology for determining minimally clinically important differences in acute pain intensity with the double...

Area of Science:

• Pain research
• Clinical trial methodology
• Quantitative psychology

Background:

• Minimum clinically important differences (MCIDs) for acute pain intensity lack robust establishment.
• Conventional MCID estimation relies on potentially inaccurate anchor-based reference scales.
• The double stopwatch technique is the gold standard for measuring time to meaningful pain relief but presents data censoring challenges.

Purpose of the Study:

• To propose and validate a novel stopwatch-based methodology for determining MCIDs in acute pain.
• To address the limitations of conventional methods by incorporating individualized, time-to-event data.
• To provide a more accurate and less biased approach for assessing meaningful pain changes in clinical research.

Main Methods:

• Utilized the double stopwatch technique to capture individualized meaningful pain relief.
• Developed a stopwatch-based MCID methodology to classify pain changes based on participant perception and study cut-offs.
• Employed cluster bootstrapping for variance estimates to assess the performance (sensitivity, specificity) of different thresholds.
• Incorporated data from participants who did not achieve meaningful relief to handle censoring and mitigate bias.

Main Results:

• The proposed methodology enables direct classification of meaningful pain changes for each participant.
• It effectively incorporates censored data, avoiding bias inherent in standard methods.
• Performance metrics like sensitivity and specificity can be reliably estimated for various MCID thresholds.
• Demonstrated the advantages of the stopwatch-based approach using data from a third molar extraction trial.

Conclusions:

• The stopwatch-based MCID methodology offers a significant advancement over conventional approaches for acute pain.
• This technique provides a reliable basis for evaluating the meaningfulness of pain relief in clinical trials.
• It is adaptable for establishing MCIDs across diverse acute pain settings, enhancing clinical relevance.